Search Results for: FVIII

Kogenate for Hemophilia A

Kogenate is an approved treatment for the symptoms of hemophilia A, developed and marketed by Bayer. How Kogenate works Hemophilia A is a genetic condition that causes the blood ... Read more

BAY 94-9027

BAY 94-9027, developed by Bayer, is an investigational treatment for severe hemophilia A. It is a PEGylated molecule of recombinant factor VIII in which the B-domain, a region within ... Read more